The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice

被引:29
|
作者
Burns, Ted M. [1 ]
机构
[1] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA
来源
关键词
MG composite; myasthenia gravis; outcome measures; MGC; MG; MYCOPHENOLATE-MOFETIL; RECOMMENDATIONS; CYCLOSPORINE; RELIABILITY; VALIDATION; STANDARDS; IVIG;
D O I
10.1111/j.1749-6632.2012.06812.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The myasthenia gravis composite (MGC) was constructed by selecting the best performing items from three commonly used, MG-specific scales. The response categories of the items were subsequently weighted for importance. The MGC, which takes less than five minutes to complete, is made up of three ocular, three bulbar, one respiratory, one neck, and two limb items. After its construction, the MGC was validated in an 11-center scale validity study. During the validation study, which included test-retest analysis, it was determined that a 3-point improvement in MGC score reliably indicates clinical improvement. A 3-point improvement in MGC also appears to be meaningful to the patient. Rasch analysis of the MGC confirmed that all 10 items belong and can be summed to provide a total score, and that the weights given to the response categories of the items are appropriate.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 50 条
  • [41] VIBRANCE-MG: CLINICAL TRIAL OF NIPOCALIMAB IN PEDIATRIC MYASTHENIA GRAVIS
    Ramchandren, Sindhu
    Black, Shawn
    Sun, Hong
    MUSCLE & NERVE, 2022, 66 : S50 - S50
  • [42] Vibrance-mg: Clinical Trial of Nipocalimab in Pediatric Myasthenia Gravis
    Ramchandren, Sindhu
    Black, Shawn
    Sun, Hong
    NEUROLOGY, 2022, 99 (23) : S41 - S41
  • [43] GD03 Identifying core outcome domains and development of a cutaneous leishmaniasis core outcome measure for use in clinical practice and trials
    Senarathne, Sujai
    Ranasinghe, Shalindra
    Kahawita, Indira
    Somaratne, Vijani
    Wickramasinghe, Amila
    Parkash, Vivak
    Lacey, Charles
    Kaye, Paul
    Layton, Alison
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [44] Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
    Cortes-Vicente, Elena
    Alvarez-Velasco, Rodrigo
    Pla-Junca, Francesc
    Rojas-Garcia, Ricard
    Paradas, Carmen
    Sevilla, Teresa
    Casasnovas, Carlos
    Teresa Gomez-Caravaca, Maria
    Pardo, Julio
    Ramos-Fransi, Alba
    Lara Pelayo-Negro, Ana
    Gutierrez-Gutierrez, Gerardo
    Turon-Sans, Janina
    Lopez de Munain, Adolfo
    Guerrero-Sola, Antonio
    Jerico, Ivonne
    Asuncion Martin, Maria
    Dolores Mendoza, Maria
    Moris, German
    Velez-Gomez, Beatriz
    Garcia-Sobrino, Tania
    Pascual-Goni, Elba
    Reyes-Leiva, David
    Illa, Isabel
    Gallardo, Eduard
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2022, 9 (02): : 122 - 131
  • [45] The long-term clinical outcome of myasthenia gravis in patients with thymoma
    Bril, V
    Kojic, J
    Dhanani, A
    NEUROLOGY, 1998, 51 (04) : 1198 - 1200
  • [46] Clinical outcome of thymectomy in myasthenia gravis patients: A report from Iran
    Seyfari, Benyamin
    Fatehi, Farzad
    Shojaiefard, Abolfazl
    Jafari, Mehdi
    Ghorbani-Abdehgah, Ali
    Nasiri, Shirzad
    Yaghoobi-Notash, Aidin
    Molavi, Behnam
    Latif, Amir Hossein
    Eslamian, Reza
    Mir, Ali
    Soroush, Ahmadreza
    IRANIAN JOURNAL OF NEUROLOGY, 2018, 17 (01) : 1 - 5
  • [47] Clinical course and outcome of Covid-19 in patients with myasthenia gravis
    Aktoz, Gonulden
    Boz, Cavit
    Zengin, Serap
    Okumus, Aleyna Caglar
    Horozoglu, Hilal
    Kara, Fatma
    Oral, Ebru
    Ozmenoglu, Mehmet
    NEUROLOGICAL RESEARCH, 2023, 45 (06) : 583 - 589
  • [48] Clinical and pathologic predictors of outcome in thymoma-associated Myasthenia gravis
    López-Cano, M
    Ponseti-Bosch, JM
    Espin-Basany, E
    Sánchez-García, JL
    Armengol-Carrasco, M
    ANNALS OF THORACIC SURGERY, 2003, 76 (05): : 1643 - 1649
  • [49] Clinical characteristics, treatment and outcome of nivolumab-induced myasthenia gravis
    Chunjiang Wang
    Hanqing Zeng
    Weijin Fang
    Liying Song
    Investigational New Drugs, 2023, 41 : 333 - 339
  • [50] PATIENTS' EXPECTATIONS OF THERAPEUTIC OUTCOME AFFECT THE CLINICAL RESPONSE IN MYASTHENIA GRAVIS
    Frisaldi, E.
    Ferrero, B.
    Lopiano, L.
    Shaibani, A.
    Benedetti, F.
    MUSCLE & NERVE, 2019, 60 : S10 - S10